GLMD
Galmed·NASDAQ
--
--(--)
--
--(--)
GLMD fundamentals
Galmed (GLMD) released its earnings on Nov 26, 2025: revenue was -- (YoY --), beat estimates; EPS was -0.33 (YoY --), beat estimates.
Revenue / YoY
--
--
EPS / YoY
-0.33
--
Report date
Nov 26, 2025
EPS
Actual | -52.2 | -46.8 | -57.6 | -86.4 | -68.4 | -59.4 | -55.8 | -54 | -43.2 | -27 | -36.9 | -18 | -13.08 | -3.24 | -1.94 | -0.62 | -0.63 | -0.33 | |||||||||||||||
Forecast | -65.5714 | -56.5714 | -42.84 | -65.3958 | -67.5 | -67.32 | -63 | -43.2 | -56.52 | -41.76 | -29.25 | -25.2 | -18 | -4.08 | -3.6 | -3.84 | -0.89 | -0.83 | -0.54 | ||||||||||||||
Surprise | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | +20.39% | +17.27% | -34.45% | -32.12% | -1.33% | +11.76% | +11.43% | -25.00% | +23.57% | +35.34% | -26.15% | +28.57% | +27.33% | 0.00% | +10.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | +30.34% | +24.10% | +38.89% |
Revenue
Actual | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -- | -- | -- | -- | -- | -- | -- | -- | 1.64M | 1.54M | -- | -- |
Forecast | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -- | -- | -- | -- | 1.54M | 1.45M | 1.37M |
Surprise | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Earnings Call
You can ask Aime
What factors drove the changes in Galmed's revenue and profit?What is Galmed's gross profit margin?What is the market's earnings forecast for Galmed next quarter?What does Galmed do and what are its main business segments?What were the key takeaways from Galmed's earnings call?What guidance did Galmed's management provide for the next earnings period?What were the key takeaways from Galmed’s earnings call?Did Galmed beat or miss consensus estimates last quarter?
